SEQUENTIAL HIGH-DOSE THERAPY (HDT) FOR HIGH-RISK (HR) INTERMEDIATE AND HIGH-GRADE ADULT PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) - A PILOT-STUDY OF GOELAMS GROUP

Authors
MILPIED N DELWAIL V SENSEBE L IFRAH N CASASSUS P COLOMBAT P DECONINCK E LAMY T HAROUSSEAU JL
Citation
N. Milpied et al., SEQUENTIAL HIGH-DOSE THERAPY (HDT) FOR HIGH-RISK (HR) INTERMEDIATE AND HIGH-GRADE ADULT PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) - A PILOT-STUDY OF GOELAMS GROUP, Blood, 88(10), 1996, pp. 3867-3867
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
2
Supplement
1
Pages
3867 - 3867
Database
ISI
SICI code
0006-4971(1996)88:10<3867:SHT(FH>2.0.ZU;2-Y